Breathe BioMedical Inc. (BRTH)

Breathe BioMedical was planning to go public, but the IPO was withdrawn on Oct 28, 2024.

IPO Price Range

$4.00 - $6.00

Shares Offered

2,625,000

Deal Size

$13.13M

Breathe BioMedical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	57	-	-	-
Enterprise Value	58	-	-	-
Debt / Equity Ratio	19.10	1.84	2.66	-
Debt / EBITDA Ratio	-	-0.24	-0.29	-
Debt / FCF Ratio	-0.47	-0.37	-0.35	-
Quick Ratio	-	1.20	0.98	-
Interest Coverage	-	-516.73	-	-
Return on Equity (ROE)	-6075.51%	-797.11%	-963.86%	-
Return on Assets (ROA)	-	-176.03%	-132.36%	-
Return on Capital (ROIC)	-325.59%	-308.17%	-319.30%	-

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).